CORE SCIENTIFIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.695 USD | -0.27% |
|
+1.51% | 0.00% |
| 05-08 | Earnings Flash (CORZ) CORE SCIENTIFIC Posts Q1 Revenue $179.3M | MT |
| 05-08 | Core Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 656.9 | - | - |
| Enterprise Value (EV) 1 | 656.9 | 656.9 | 656.9 |
| P/E ratio | 5.28 x | 14.5 x | -185 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.17 x | 1.02 x | 1.04 x |
| EV / Revenue | 1.17 x | 1.02 x | 1.04 x |
| EV / EBITDA | 2.92 x | 2.51 x | 3.08 x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 177,783 | - | - |
| Reference price 2 | 3.695 | 3.695 | 3.695 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 544.5 | 640.3 | 502.4 | 562.4 | 644.6 | 630.1 |
| EBITDA 1 | 238.9 | 174.9 | 170 | 224.8 | 262 | 213.6 |
| EBIT 1 | 166.5 | -2,110 | 8.961 | 82.59 | 104.1 | 42.6 |
| Operating Margin | 30.58% | -329.46% | 1.78% | 14.69% | 16.14% | 6.76% |
| Earnings before Tax (EBT) 1 | 63.08 | -2,163 | -245.8 | 202 | 77.44 | 4 |
| Net income 1 | 47.31 | -2,146 | -246.5 | 201.4 | 75.19 | -3.6 |
| Net margin | 8.69% | -335.2% | -49.06% | 35.8% | 11.66% | -0.57% |
| EPS 2 | - | - | -0.6500 | 0.7000 | 0.2550 | -0.0200 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/03/22 | 04/04/23 | 12/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 301.8 | 192.5 | 164 | 162.6 | 121.2 | 120.7 | 126.9 | - | 141.9 | 179.3 | 138.4 | 112.5 | 132.2 | 136.2 | 154.6 |
| EBITDA 1 | 150.9 | 93.04 | 59.11 | 17.54 | 5.175 | 28.66 | 44.82 | - | 57.53 | 88 | 61.26 | 24.58 | 50.95 | 59.81 | 61.8 |
| EBIT 1 | 122.4 | 50.9 | -1,095 | -401.4 | -636.1 | -3.695 | 9.384 | - | 3.934 | 55.23 | 23.59 | -13.3 | 13.18 | 20.94 | 22.52 |
| Operating Margin | 40.57% | 26.44% | -667.57% | -246.89% | -524.6% | -3.06% | 7.39% | - | 2.77% | 30.8% | 17.04% | -11.82% | 9.97% | 15.37% | 14.57% |
| Earnings before Tax (EBT) 1 | 76.97 | -423.8 | -908.4 | -424.2 | -456.3 | -11.58 | -9.131 | - | -195.4 | 210.9 | 12.25 | -24.37 | 4.817 | 14.14 | 15.84 |
| Net income 1 | 60.51 | -466.2 | -861.7 | -434.8 | -434.8 | -11.68 | -9.26 | -41.15 | -195.7 | 210.7 | 9.554 | -24.37 | 4.417 | 13.94 | 15.84 |
| Net margin | 20.05% | -242.16% | -525.5% | -267.45% | -358.64% | -9.68% | -7.3% | - | -137.88% | 117.51% | 6.9% | -21.66% | 3.34% | 10.23% | 10.25% |
| EPS 2 | - | - | - | - | - | - | - | - | -0.5100 | 0.7800 | 0.0500 | -0.1150 | 0.0200 | 0.0500 | 0.0550 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 29/03/22 | 12/05/22 | 11/08/22 | 22/11/22 | 04/04/23 | 15/05/23 | 04/08/23 | 06/11/23 | 12/03/24 | 08/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 29/03/22 | 04/04/23 | 12/03/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.695
USD
Average target price
6.75
USD
Spread / Average Target
+82.68%
EPS Revisions
- Stock Market
- Equities
- CORZ Stock
- Financials Core Scientific, Inc.
